Malignant Melanoma Clinical Trials 2024

Malignant Melanoma research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in malignant melanoma clinical trials today.

Popular Trials

Alkylating agents

Pembrolizumab + Chemotherapy for Metastatic Melanoma

Recruiting3 awardsPhase 2

Montreal, Quebec

This trial is testing a new combination drug therapy for melanoma that has spread or can't be removed by surgery.

Popular Filters

Trials With No Placebo

CAR T-cell Therapy

RAPA-201 Cell Therapy for Melanoma

Recruiting1 awardPhase 2

Hackensack, New Jersey

This trial is for patients with advanced melanoma that has come back after previous treatment. It will be done at multiple sites and will have two stages to test the effectiveness of a new treatment.

Device

Focused Ultrasound Radiosensitization for Melanoma

Recruiting1 awardPhase 1

Toronto, Ontario

This trial will study a new therapy combining ultrasound and radiation to safely treat diseases in people.

Chemotherapy

DYP688 for Metastatic Uveal Melanoma

Recruiting1 awardPhase 1 & 2

Boston, Massachusetts

This trial is testing a new drug called DYP688 to see if it can help treat patients with specific types of skin cancer that have certain genetic mutations. The study aims to find out if the drug is safe and effective in shrinking tumors in these patients.

MAPK Pathway Inhibitor

Tovorafenib + Pimasertib for Cancer

Recruiting1 awardPhase 1 & 2

Los Angeles, California

This trial is testing Tovorafenib, a drug that blocks proteins needed for cancer cell growth, in patients aged 12+ with hard-to-treat melanoma or other solid tumors.

Checkpoint Inhibitor

Neoadjuvant Ipilimumab + Nivolumab for Melanoma

Recruiting2 awardsPhase 3

Houston, Texas

This trial is testing two treatment plans for patients with stage III melanoma. One plan uses two drugs before surgery, while the other uses surgery first followed by one of the drugs. The goal is to see which plan works better at stopping the cancer from coming back. These drugs have been shown to improve survival rates in patients with advanced melanoma.

Tyrosine Kinase Inhibitor

Cabozantinib for Rare Cancers in Young Patients

Recruiting1 awardPhase 2

Birmingham, Alabama

This trialstudies how well cabozantinib-s-malate works to treat rare tumors in younger patients, blocking enzymes needed for tumor growth and blood vessel growth.

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.